NYBOP's "Double Down" Turns Into a Double Back: New York Softens Shared Pharmacy Services Requirements for Non-Resident Pharmacies

Earlier this year, New York regulators appeared to "double down" on an aggressive interpretation of the state's new shared pharmacy services framework, creating significant concern for pharmacies operating centralized and shared services models. As discussed in our prior alert, the New York Board of Pharmacy had interpreted the new shared services statute and rules to require individual New York pharmacist licensure for pharmacists employed by non-resident pharmacies participating in shared services arrangements for New York prescriptions.

In a notable shift, the New York Board of Regents approved amendments on May 19, 2026 that narrow portions of that interpretation and provide meaningful relief for non-resident pharmacies and shared services arrangements. The amendments were adopted following stakeholder concerns that the regulations may have inadvertently captured certain interstate pharmacy operations and imposed substantial operational burdens on centralized pharmacy models.

Key Changes:

Applicability of the shared pharmacy services framework narrowed

The amendments introduce a new applicability provision that may significantly limit the overall reach of the shared pharmacy services rules. Specifically, the shared services rules now apply when a New York-domiciled pharmacy participates in shared pharmacy services for purposes of processing or filling prescriptions or orders for New York patients. Put differently, the framework is no longer written broadly enough to potentially capture every prescription ultimately destined for a New York patient merely because it passes through an out-of-state shared services model. This threshold clarification is important because it shifts the analysis from "Is a New York patient involved?" to the more targeted question of whether a New York-domiciled pharmacy is participating in the shared services arrangement itself.

Direct-ship non-resident pharmacies excluded from shared services requirements

The amendments clarify that registered non-resident pharmacies that ship prescriptions directly to New York patients, but do not work directly with a New York-registered pharmacy via a shared services arrangement, are not subject to New York's shared pharmacy services requirements. Such pharmacies remain subject to New York's general non-resident pharmacy laws and regulations but will not be swept into the shared services framework solely because they dispense into New York. For many mail-order, specialty, and centralized dispensing operations, this clarification removes substantial uncertainty.

Home-state pharmacist licensure may satisfy requirements

The amendments also significantly revise the Board of Pharmacy’s earlier interpretation regarding individual pharmacist licensure. Rather than requiring all pharmacists engaged in shared services for a New York patient to be individually licensed in New York, pharmacists may now:

1. Hold an active New York pharmacist license; or
2. Be licensed and in good standing in their home state and working for a pharmacy holding a nonresident pharmacy permit in New York.

The regulations also revise the definition of "registered pharmacist" to expressly include pharmacists licensed and in good standing in their home states when employed by registered non-resident pharmacies. Amendment commentary indicated that accountability concerns remain addressed because New York retains disciplinary jurisdiction over non-resident establishments and pharmacist conduct occurring within those operations.

Why This Matters

This development represents a meaningful course correction for pharmacies operating centralized and shared services models. Had the prior interpretation remained in place, many organizations would have faced significant operational burdens, including:

1. Obtaining New York pharmacist licensure for potentially large numbers of pharmacists performing remote functions;
2. Revisiting staffing and centralized operations models; and
3. Reassessing shared services arrangements involving New York patients.

While the amendments do not eliminate New York's shared pharmacy services requirements, they narrow the framework's reach and appear intended to avoid unintentionally burdening interstate pharmacy operations.

The initial implementation of New York's shared pharmacy services framework created concern that the state had effectively expanded its regulatory reach beyond traditional shared pharmacy arrangements. Today's action pulls back from that position and provides additional clarity regarding how New York intends these requirements to operate in practice.

Pharmacies operating centralized dispensing, remote order entry, shared verification, or broader shared services arrangements involving New York patients should assess whether these changes alter prior compliance assumptions and operational planning.

Quarles will continue to monitor developments and engage with regulators as appropriate. If you would like to discuss the impact of this guidance on your operations, please contact your Quarles attorney or:

• Nick Meza: (602) 229-5439 / nicholas.meza@quarles.com
• Brenda Maloney Shafer: (602) 229-5774 / brenda.shafer@quarles.com
• Roger Morris: (602) 229-5269 / roger.morris@quarles.com